Detected ·
Nouscom
€120MSeries D
Nouscom closed an oversubscribed €120M ($135M) Series D financing round to advance NOUS-209, its off-the-shelf immunotherapy for cancer interception in Lynch Syndrome carriers.
- Website
- —
- linkedin.com/company/18328527
- Amount
- €120 000 000 EUR
- Stage
- Series D
- Event
- Funding round
- Detected
- 2026-10-19 20:09:46 UTC
- Signal ID
- a510b935-9521-4a0b-ae90-5877a600c0b2
As the API returns it
{
"id": "a510b935-9521-4a0b-ae90-5877a600c0b2",
"created_at": "2026-10-19T20:09:46.366696Z",
"company_name": "Nouscom",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/18328527",
"event_type": "funding",
"funding_amount": 120000000,
"funding_currency": "EUR",
"funding_stage": "series_d",
"message": "*Nouscom closed an oversubscribed €120M ($135M) Series D financing round to advance NOUS-209, its off-the-shelf immunotherapy for cancer interception in Lynch Syndrome carriers.*"
}